EXPONENT INC·4

Mar 16, 4:16 PM ET

Corrigan Catherine 4

4 · EXPONENT INC · Filed Mar 16, 2026

Research Summary

AI-generated summary of this filing

Updated

Exponent (EXPO) CEO Catherine Corrigan Receives Award of 17,814 Shares

What Happened
Catherine Corrigan, President & CEO and a director of Exponent Inc. (EXPO), received an award/derivative acquisition of 17,814 shares on 2026-03-13. The filing lists the transaction as an award (code A) of derivative securities; no per-share price or cash value is reported (N/A).

Key Details

  • Transaction date: 2026-03-13; Form 4 filed: 2026-03-16 (filed within the SEC’s 2-business-day requirement).
  • Shares acquired: 17,814 derivative shares. Price/value: not specified (N/A).
  • Shares owned after transaction: not disclosed in the provided filing.
  • Footnotes: F1 indicates a 1-for-1 conversion; F2 is not applicable.
  • Transaction type: Award/grant of derivative securities (not an open-market purchase or sale).

Context
The filing reports an award of derivative securities, which are typically used for executive compensation (for example, restricted stock units or performance-based awards), though the exact instrument is not specified. Awards are compensation events rather than purchases or sales and do not by themselves signal an immediate change in market exposure unless followed by later sales or exercises.

Insider Transaction Report

Form 4
Period: 2026-03-13
Corrigan Catherine
DirectorPresident & CEO
Transactions
  • Award

    Restricted Stock Units

    [F1][F2]
    2026-03-13+17,81417,814 total
    From: 2030-03-13Exp: 2030-03-13Common Stock (17,814 underlying)
Footnotes (2)
  • [F1]1-for-1.
  • [F2]Not applicable.
Signature
By: Wendy Whitehouse For: Catherine Corrigan|2026-03-16

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT